Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 13Thoracic 5Other hematologic neoplasm 5Genitourinary 5Gastrointestinal 5Lymphoid 3Tumor-Agnostic 2Sarcoma 2Head & Neck 2Gynecologic 2CNS 2Plasma cell 1Classical hematology 1

Conditions

Neoplasms 2

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Physical Therapy Modalities × Tumor-Agnostic × Clear all
NCT06170385 2026-02-06

PEACE

University of Alberta

Phase NA Completed
10 enrolled
Tumor-Agnostic

Neoplasms

NCT02306252 2017-09-12

CARE Program

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
67 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡